Tadalafil, A Phosphodiesterase Inhibitor Protects Stem Cells Over Longer Period Against Hypoxia/Reoxygenation Injury Through Stat3/Pkg-I Signaling

Abstract

Pharmacological preconditioning (PC) with tadalafil, a PDE5A inhibitor, enhances protein kinase G-1 (PKG-I) activity, resulting in stem cell survival. Protection by PC had two different phases, early (2 h) and late (24 h). However, the mechanism of protection during these phases remained grossly unknown. Mesenchymal stem cells (MSCs) from adult male Fischer-344 rats were cultured and pretreated with tadalafil (100 μM) for an hour and subjected to 2 h of hypoxia (1% O2), followed by reoxygenation (HR: in vitro model mimicking ischemia/reperfusion). We observed (i) increased MSC survival with reduced cell cytotoxicity as revealed by low lactate dehydrogenase release and trypan blue staining, respectively, in tadalafil-treated cells upon HR; (ii) decrease in TUNEL positivity as well as caspase activity; (iii) an increase in pAkt/Akt, iNOS, eNOS, and pGSK3β/GSK3β during the early protection phase of PC, and this protection seemed to be a spontaneous adaptive response of MSCs against HR and was independent of tadalafil, whereas an increase in Bcl2/Bax was tadalafil dependent; and (iv) during the late phase, we observed phosphorylation of STAT3 at serine727, leading to its entry inside the nucleus and binding onto the promoter of PKG-I by three-fold (P<0.05). In conclusion, an increase in Bcl2/Bax during the early phase and transcriptional upregulation of PKG-I by STAT3 during the late phase were responsible for stem cell protection by tadalafil against ischemic injury.

Publication Date

6-1-2015

Publication Title

Stem Cells and Development

Volume

24

Issue

11

Number of Pages

1332-1341

Document Type

Article

Personal Identifier

scopus

DOI Link

https://doi.org/10.1089/scd.2014.0288

Socpus ID

84929581820 (Scopus)

Source API URL

https://api.elsevier.com/content/abstract/scopus_id/84929581820

This document is currently not available here.

Share

COinS